HealthNotableConfirmedDeveloping
5.7
Merck and Moderna report positive Phase 3 trial results for personalized melanoma vaccine
Premium Times NigeriaLO·US·about 22 hours ago
Medical analysis clarifies that current cancer 'vaccines' function primarily as immunotherapies rather than traditional preventative inoculations. The report highlights significant limitations in clinical application, emphasizing that these treatments are currently tailored to specific patient profiles rather than serving as universal cures.